Flu treatment (in immunocompromised patients):
dose
for 10 days*
Flu prevention:
dose
for 10 days
40kg or more
12.5ml** two times a day
12.5ml** two times a day
12.5ml** once a day
*For patients with a weakened immune system, treatment is for 10 days.
**12.5ml can be prepared with a 5ml dose and a 7.5ml dose
Children 1 to 12 years old
Body weight | Flu treatment: | Flu treatment (in immunocompromised patients): | Flu prevention: for 10 days |
10 to15kg | 5.0 ml two times a day | 5.0 ml two times a day | 5.0 ml once a day |
More than 15kg and up to 23kg | 7.5 ml two times a day | 7.5 ml two times a day | 7.5 ml once a day |
More than 23kg and up to 40kg | 10.0 ml two times a day | 10.0 ml two times a day | 10.0 ml once a day |
More than 40kg | 12.5 ml** two times a day | 12.5 ml** two times a day | 12.5 ml** once a day |
*For children with a weakened immune system, treatment is for 10 days.
**12.5 ml can be prepared with a 5 ml dose and a 7.5 ml dose
Infants under 1 year old (0 to 12 months)
The administration of Tamiflu to children under 1 year of age for flu prevention during a pandemic should be done on a medical basis after considering the potential benefit versus any potential risk to the child.
A 3ml oral dispenser (graduated with 0.1ml markings) should be used for the dosing in infants under 1 year of age who require 1 to 3ml of the Tamiflu oral suspension.
Body weight | Flu treatment: | Flu treatment (in immunocompromised patients): | Flu prevention: for 10 days | Dispenser size to use |
3kg | 1.5ml two times a day | 1.5ml two times a day | 1.5ml once a day | 3ml |
3.5kg | 1.8ml two times a day | 1.8ml two times a day | 1.8ml once a day | 3ml |
4kg | 2.0ml two times a day | 2.0ml two times a day | 2.0ml once a day | 3ml |
4.5kg | 2.3ml two times a day | 2.3ml two times a day | 2.3ml once a day | 3ml |
5kg | 2.5ml two times a day | 2.5ml two times a day | 2.5ml once a day | 3ml |
5.5kg | 2.8ml two times a day | 2.8ml two times a day | 2.8ml once a day | 3ml |
6 kg | 3.0ml two times a day | 3.0ml two times a day | 3.0ml once a day | 3ml |
>6 to 7 kg | 3.5ml two times a day | 3.5ml two times a day | 3.5ml once a day | 10ml |
>7 to 8 kg | 4.0ml two times a day | 4.0ml two times a day | 4.0ml once a day | 10ml |
>8 to 9 kg | 4.5ml two times a day | 4.5ml two times a day | 4.5ml once a day | 10ml |
>9 to 10 kg | 5.0ml two times a day | 5.0ml two times a day | 5.0ml once a day | 10ml |
*For patients with a weakened immune system, treatment is for 10 days.
If you take more Tamiflu than you should
Stop taking Tamiflu and consult your doctor or pharmacist immediately.
In many cases of overdose, no adverse effects were reported. When adverse effects were reported, they were similar to those that occurred with normal doses and are included in section 4.
More frequent cases of overdose with Tamiflu have been reported in children than in adults and adolescents. Caution should be exercised when preparing Tamiflu liquid for children and when administering Tamiflu capsules or liquid to children.
If you forget to take Tamiflu
Do not take a double dose to make up for the missed dose.
If you interrupt treatment withTamiflu
No adverse effects occur when stopping Tamiflu. However, if you stop taking Tamiflu before completing the treatment prescribed by your doctor, flu symptoms may recur. Always complete the treatment prescribed by your doctor.
If you have any other questions about the use of this medication, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everyone will experience them. Many of these side effects can be caused by the flu.
Since the marketing of oseltamivir, the following serious side effects have rarely been reported:
?Anaphylactic and anaphylactoid reactions: severe allergic reactions, with swelling of the face and skin, itchy rash, low blood pressure, and difficulty breathing.
?Liver disorders (fulminant hepatitis, liver function disorder and jaundice): yellowing of the skin and eyes, change in stool color, changes in behavior.
?Angioneuritic edema: severe sudden swelling of the skin mainly around the head and neck area, including eyes and tongue, with difficulty breathing.
?Stevens-Johnson syndrome and toxic epidermal necrolysis: a severe allergic reaction that can be life-threatening, with severe inflammation of the outer and possibly inner skin, initially with fever, sore throat, and fatigue, itchy rash, with blistering, peeling, and large areas of skin peeled, possible difficulty breathing and low blood pressure.
?Gastrointestinal bleeding: prolonged bleeding of the intestine or vomiting blood.
?Neuropsychiatric disorders, as described below.
If you notice any of these symptoms, seek medical help immediately.
The most frequently reported side effects (very common and common) for Tamiflu are:
?Unpleasant feeling or discomfort (nausea, vomiting), stomach pain, stomach discomfort, headache, and pain.
Seek medical help immediately
(These may affect up to 1 in 1,000 people)
During treatment with Tamiflu, rare but serious side effects have been reported, including:
?Seizures and delirium, including altered levels of consciousness.
?Confusion, abnormal behavior.
?Delirious disorders, hallucinations, agitation, anxiety, nightmares.
These events were mainly reported in children and adolescents and often began suddenly and had a rapid resolution. In very rare cases, these events had resulted in self-harm, some with fatal outcome. These neuropsychiatric events have also been reported in patients with flu who were not taking Tamiflu.
?Patients, especially children and adolescents, should be closely monitored to detect the changes in behavior described above.
If you notice any of these symptoms, especially in younger patients, seek medical help immediately.
Adults and adolescents 13 years and older
Very common side effects
(may affect more than 1 in 10 people)
?Headache
?Nausea
Common side effects
(may affect up to 1 in 10 people)
?Cough
?Fever
?Coughing
?Dizziness
?Fever
?Pain
?Pain in the limbs
?Coughing up mucus
?Difficulty sleeping
?Sore throat
?Stomach pain
?Tiredness
?Feeling full in the upper abdomen
?Upper respiratory tract infections (inflammation of the nose, throat, and sinuses)
?Stomach discomfort
?Vomiting
Uncommon side effects
(may affect up to 1 in 100 people)
?Allergic reactions
?Altered level of consciousness
?Seizure
?Alterations in heart rhythm
?Mild to severe liver function disorders
?Skin reactions (inflammation of the skin, red itchy rash, scaly skin)
Rare side effects
(may affect up to 1 in 1,000 people)
?Thrombocytopenia (reduced platelet count)
?Eye disorders
Children 1 to 12 years old
Very common side effects
(may affect more than 1 in 10 people)
?Cough
?Stuffy nose
?Vomiting
Common side effects
(may affect up to 1 in 10 people)
?Conjunctivitis (red, watery, or painful eyes)
?Inflammation of the ears and other ear disorders
?Headache
?Nausea
?Coughing
?Stomach pain
?Feeling full in the upper abdomen
?Stomach discomfort
Uncommon side effects
(may affect up to 1 in 100 people)
?Skin inflammation
?Middle ear disorder (tympanic membrane)
Infants under 1 year old
The side effects reported in children aged 0 to 12 months are mostly similar to the side effects reported in older children (from 1 year). In addition, diarrhea and diaper dermatitis have been reported.
If you consider that any of the side effects you are experiencing are severe or if you appreciate any side effect not mentioned in this leaflet, inform your doctor or pharmacist. However,
?if you or your child are ill several times, orif the flu symptoms worsen or the fever continues,
Inform your doctor as soon as possible..
Reporting of side effects
If you experience any type of side effect, consult your doctor, even if it is a possible side effect that does not appear in this leaflet. You can also report them directly through thenational reporting system included in theAppendix V.
By reporting side effects, you can contribute to providing more information on the safety of this medicine.
Keep this medication out of the reach and sight of children.
Do not use this medication after the expiration date that appears on the packaging and on the bottle after CAD. The expiration date is the last day of the month indicated.
Powder: Do not store above 30°C.
After reconstitution, the suspension can be stored at room temperature (below 25°C) for 10 days.
Medicines should not be disposed of through drains or in the trash. Ask your pharmacist how to dispose of the containers and medications that you no longer need. This will help protect the environment.
Composition of Tamiflu
?The active ingredient is oseltamivir(6mg/ml of oseltamivir after reconstitution)
?The other components are: sorbitol (E420), sodium dihydrogen citrate (E331[a]), xanthan gum (E415), sodium benzoate (E211), sodium saccharin (E954), titanium dioxide (E171), and tutti frutti aroma (including corn maltodextrins, propylene glycol, arabic gum E414, and natural-like flavoring substances, mainly from banana, pineapple, and peach aromas).
Appearance of the product and contents of the package
Oral suspension powder.
The powder is a white to pale yellow granulated or agglomerated powder.
Tamiflu 6mg/ml oral suspension powder is available in bottles containing 13g of powder to be mixed with 55ml of water.
The package also contains 1 plastic measuring cup (55ml), 1 plastic bottle adapter (to help introduce the product into the dispenser), 1 3ml oral dispenser, and 1 10ml oral dispenser (to administer the correct dose of the medication orally). The oral dispenser has milliliter (ml) markings for the medication (see figures inUser Instructions).
For more details on how to prepare the oral suspension and how to measure and take the medication, please read the page onUser Instructions.”
Marketing Authorization Holder and Responsible Manufacturer
Roche Registration GmbH
Emil-Barell-Strasse 1
79639 Grenzach-Wyhlen
Germany
Roche Pharma AG
Emil-Barell-Str. 1,
D-79639 Grenzach-Wyhlen
Germany
For more information about this medication, please contact the local representative of the marketing authorization holder:
België/Belgique/Belgien N.V. Roche S.A. Tél/Tel: +32(0) 2 525 82 11 | Lietuva UAB “Roche Lietuva” Tel: +370 5 2546799 |
???????? ??????????????? ???: +359 2818 44 44 | Luxembourg/Luxemburg (Voir/siehe Belgique/Belgien) |
Ceská republika Roche s. r. o. Tel: +420 - 2 20382111 | Magyarország Roche (Magyarország) Kft. Tel: +36 - 1 279 4500 |
Danmark Roche Pharmaceuticals A/S Tlf: +45 - 36 39 99 99 | Malta (See Ireland) |
Deutschland Roche Pharma AG Tel: +49 (0) 7624 140 | Nederland Roche Nederland B.V. Tel: +31 (0) 348 438050 |
Eesti Roche Eesti OÜ Tel: + 372 - 6 177 380 | Norge Roche Norge AS Tlf: +47 - 22 78 90 00 |
Ελλ?δα Roche (Hellas) A.E. Τηλ: +30 210 61 66 100 | Österreich Roche Austria GmbH Tel: +43 (0) 1 27739 |
España Roche Farma S.A. Tel: +34 - 91 324 81 00 | Polska Roche Polska Sp.z o.o. Tel: +48 - 22 345 18 88 |
France Roche Tél: +33 (0) 147 61 40 00 | Portugal Roche Farmacêutica Química, Lda Tel: +351 - 21 425 70 00 |
Hrvatska Roche d.o.o Tel:+385 1 4722 333 | România Roche România S.R.L. Tel: +40 21 206 47 01 |
Ireland Roche Products (Ireland) Ltd. Tel: +353 (0) 1 469 0700 | Slovenija Roche farmacevtska družba d.o.o. Tel: +386 - 1 360 26 00 |
Ísland RochePharmaceuticals A/S c/o Icepharma hf Sími: +354 540 8000 | Slovenská republika Roche Slovensko, s.r.o. Tel: +421 - 2 52638201 |
Italia Roche S.p.A. Tel: +39 - 039 2471 | Suomi/Finland Roche Oy Puh/Tel: +358(0) 10 554 500 |
K?προς Γ.Α.Σταμ?της & Σια Λτδ. Τηλ: +357 - 22 76 62 76 | Sverige Roche AB Tel: +46 (0) 8 726 1200 |
Latvija Roche Latvija SIA Tel: +371 - 6 7039831 | United Kingdom (Irlanda del Norte) Roche Products (Irlanda) Ltd. Tel: +44 (0) 1707 366000 |
Last update of thisleaflet:
The detailed information about this medication is available on the website of the European Medicines Agency:http://www.ema.europa.eu/.
User Instructions
There are two steps to take the oral suspension.
Step 1 Prepare a new bottle of the medication
You may have prepared the medication when you picked up your prescription. If not, you can prepare it easily yourself. See the first group of instructions.You only need to do this once, when you start treatment.
Step 2 Measure and give the correct dose
Shake the suspension well and extract the recommended dose with the dispenser. See the second group of instructions. You will need to do this every time you need to take a dose.
Step 1 Prepare a new bottle of the medication
You will need:
?The bottle containing the Tamiflu powder (in the medication package)
?The bottle cap (in the medication package)
?A plastic measuring cup (in the medication package)
?The plastic bottle adapter (in the medication package)
?Water
?Tap the bottle to loosen the powder
Gently tap the closed bottle several times to loosen the powder.
?Use the measuring cup to measure 55ml of water
The measuring cup that comes with the package has a line marked to show you the exact amount.
Fill it with water up to the indicated level.
?Add the water, close and shakePour all the water from the measuring cup into the bottle, over the powder
You must always use 55ml of water, regardless of the dose you need.
Put the cap on the bottle. Shake the bottle well for 15 seconds.
?Press the adapter
Open the bottle and press the bottle adapter well into the neck of the bottle.
?Close the bottle again
Twist the cap tightly onto the top of the bottle, which now includes the adapter. This will ensure that the adapter fits into the bottle in the correct position.
You now have a bottle ofTamiflu oral suspension ready to measure and administer a dose. You will not need to prepare it again until you start a new bottle.
Step 2: Measure and give the correct dose
You will need:
?A prepared Tamiflu oral suspension bottle
?Depending on the dose needed, you will need a 3ml oral dispenser (orange plunger, 0.1ml graduation) or a 10ml oral dispenser (transparent plunger, 0.5ml graduation) included in the package.
?For doses of 1.0ml to 3.0ml, the 3ml oral dispenser should be used. For doses above 3.0ml to 10ml, the 10ml oral dispenser should be used.
Always use the oral dispenser provided in the package to measure the correct dose.
?Shake the bottle
Make sure the bottle is tightly closed and then shake the Tamiflu oral suspension bottle.
Always shake well before use.
?Prepare the oral dispenser
Depending on the dose needed, use the 3ml oral dispenser (orange plunger) or the 10ml oral dispenser (transparent plunger) that comes with the package.
Pullthe plunger all the way down to the bottom of the dispenser.
?Fill the dispenser with the correct dose
Remove the cap from the bottle.
Push the tip of the dispenser into the adapter of the bottle.
Turn the combination(bottle and dispenser together)until the topis inverted.
Slowly pull the plunger to extract the medication into the dispenser.
Stop at the graduation mark corresponding to the dose you need.
Turn the combination back to the right.
Remove the dispenser from the bottle.
?Administer the medication orally
Insert the suspension directly into the mouth, pushing the plunger of the dispenser. Make sure the medication is swallowed. After taking the medication, you can drink and eat some food.
?Close the bottle, keep in a safe place
Put the cap back on the bottle. Keep out of the sight and reach of children.
Store the medication below 25°C for a maximum of 10 days. See section 5.Storage of Tamiflu,in this leaflet.
Immediately after administration, separate the parts of the dispenser and wash both under running water.
Есть вопросы по этому лекарству или вашим симптомам? Свяжитесь с лицензированным врачом для получения помощи и персонализированного ухода.